ArticleScientific reports2021

All-trans retinoic acid and protein kinase C α/β1 inhibitor combined treatment targets cancer stem cells and impairs breast tumor progression.

Damian Emilio Berardi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.